Delivery Order SPE2DB20D2014-SPE2DB24FD06N

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $20,852.08 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the provision of 4,565,177,802 units of ondansetron ODT 8 mg tablets. The contract has a period of performance through July 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for a comprehensive range of pharmaceutical and...
The Defense Logistics Agency (DLA) awarded a $1,029.66 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,749,615 units of the drug Ondansetron HCl 4 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,247.48 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp. for the supply of 4,565,469,507 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The contract has an ultimate completion date of August 16, 2024 and was awarded on August 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these critical medical supplies to support various military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $9,315.98 to Amerisourcebergen Drug Corporation's Corporate Office Division to supply 4,565,048,173 units of the prescription drug Ondansetron ODT 4 mg tablet. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $12,576.93 and a performance period through April 15, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to provide a comprehensive range of...
The Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,561,886 units of Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $12,250.59 and an ultimate completion date of August 26, 2024. This contract is not set aside for a particular business category. Amerisourcebergen, through its Corporate Office division, will be the prime contractor responsible for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The $7,954.22 firm fixed-price contract has an ultimate completion date of April 11, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,469,416 units of the prescription drug Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $1,735.60 and a period of performance through August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 8 mg tablets. The contract has a firm fixed price of $1,271.26 and an ultimate completion date of October 9, 2024. This is a delivery order contract, which is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,114,688 units of the prescription medication Ondansetron ODT 4 mg tablets. The contract has a ceiling value of $13,585.32 and a performance period extending through May 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA Troop Support Medical,...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FD06N
    Delivery Order

The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The contract is valued at $8,139.82 and has a completion date of September 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/18/24, 9:28 AM